NCT00679354 2018-08-01Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyNational Cancer Institute (NCI)Phase 2 Completed30 enrolled 19 charts